Journal

You may have seen Dr. Sanjay Gupta’s series about cannabis on CNN. He was at one time a critic of marijuana, but in a widely publicized article, “Why I Changed My Mind on Weed,” he wrote: “I traveled around the world to interview medical leaders, experts,

When Army Ranger Jesse Gould came home from Afghanistan in 2014 after his third deployment, he was suffering, both physically and emotionally. It took the Department of Veterans Affairs (VA) 2 years to process his disability claim and diagnose him with post-traumatic stress disorder

The U.S. Department of Veterans Affairs has launched clinical trials to study the effectiveness of psychedelic drugs including MDMA and psilocybin as a treatment for military veterans with post-traumatic stress disorder, addiction and other serious mental health issues. Building on previous research that has

Objectives of this learning scenario, developed by NYU Langone’s High School Bioethics Project, are to understand post-traumatic stress disorder (PTSD) and the symptoms it causes, learn how the chemical psilocybin, found in psychedelic drugs, can potentially help people who have PTSD, and discuss the

Interest in the therapeutic potential of psychedelics, having lain relatively dormant in the face of stigma and heavy regulations for decades, has reignited in the last ten years. Landmark studies showing these compounds’ effectiveness in treating some mood disorders have kickstarted a wave of